← Back to Search

Clear Speech for Sensorineural Hearing Loss

N/A
Recruiting
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Native English speaker
Age 60-90
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the speech listening portion of the experiment, up to 30 minutes.
Awards & highlights

Study Summary

This trial focuses on understanding how adults with SNHL process speech & memory, and how speaking style can help them better understand and remember what they hear.

Who is the study for?
This trial is for right-handed English speakers aged 60-90 with normal cognitive function (MoCA score ≥25). Participants can have mild to moderate sensorineural hearing loss but must not have psychiatric/neurological illnesses, eye diseases affecting pupil dilation, or be on certain drugs that alter brain function.Check my eligibility
What is being tested?
The study examines how clear speech affects the effort of listening and memory during sentence processing in older adults with sensorineural hearing loss. It uses pupillometry and brain potential measures to understand the impact of speaking style on language comprehension and memory.See study design
What are the potential side effects?
Since this trial involves non-invasive procedures like monitoring pupil response and brain activity during speech tasks, there are no direct side effects from interventions like medications. However, fatigue or discomfort from participating in testing sessions may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a native English speaker.
Select...
I am between 60 and 90 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the speech listening portion of the experiment, up to 30 minutes.
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the speech listening portion of the experiment, up to 30 minutes. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Delayed Recognition Memory
N400 amplitude
N400 latency
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Speech StudyExperimental Treatment2 Interventions
The study is a within-subjects 2 x 3 factorial design. All participants are exposed to all experimental conditions or "interventions"

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,100 Previous Clinical Trials
1,778,621 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals over the age of eighteen permitted to participate in this experiment?

"The age range to be part of this research project is between 60 and 90 years, adhering to the study's predetermined eligibility criteria."

Answered by AI

Who qualifies to take part in this clinical trial?

"This study, seeking 80 participants, is searching for individuals aged 60-90 that are able to communicate verbally."

Answered by AI

Does the clinical trial currently have space for new participants?

"According to clinicaltrials.gov, the research team is actively recruiting patients for this trial. The initial post date was September 12th 2023 and it has been updated as of September 20th 2023."

Answered by AI

How many participants are eligible for this research study?

"Affirmative, the information on clinicaltrials.gov verifies that this trial is currently enrolling members. It was initially uploaded onto the website on September 12th 2023 and updated lastly on September 20th of the same year. The study requires 80 participants from one medical site to participate in it."

Answered by AI
~37 spots leftby Oct 2024